TITLE

Correspondence letter: could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?

AUTHOR(S)
Semmekrot, Ben
PUB. DATE
January 2009
SOURCE
European Journal of Pediatrics;Jan2009, Vol. 168 Issue 1, p123
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article about lipid infusion as a risk factor for parenteral nutrition-associated cholestasis (PNAC) in low birth weight infants.
ACCESSION #
35417545

 

Related Articles

  • Reply to correspondence letter by Ben Semmekrot: Comment on: Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Il Shin, Jae; Namgung, Ran // European Journal of Pediatrics;Jan2009, Vol. 168 Issue 1, p125 

    A response by Jae Il Shin and Ran Namgung to a letter to the editor about their article on lipid infusion as a risk factor for parenteral nutrition-associated cholestasis in low birth weight infants.

  • Prednisolone.  // Reactions Weekly;7/21/2012, Issue 1411, p36 

    The article presents a case study of a male neonate who developed cholestasis after treatment with prednisolone for Kasabach-Merritt phenomenon.

  • An Unusual Cause of Cholestasis in an Infant. Ukraincik, Miro // Clinical Pediatrics;Sep1999, Vol. 38 Issue 9, p543 

    Discusses the clinical case of an infant with cholestasis. Laboratory examinations of the infant; Medical findings and diagnosis; Clinical management of the patient.

  • Neonatal cholestasis as initial manifestation of type 2 Gaucher disease: a continuum in the spectrum of early onset Gaucher disease. Elias, A. F.; Johnson, M. R.; Boitnott, J. K. // Current Medical Literature: Lysosomal Storage Disease;2013, Vol. 11 Issue 2, p53 

    A review of the article "Neonatal cholestasis as initial manifestation of type 2 Gaucher disease: A continuum in the spectrum of early onset Gaucher disease," by A. F. Elias and colleagues, which appeared in the "Journal of Industrial Microbiology and Biotechnology" in 2012, is presented.

  • Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Radetti, Giorgio; Gentili, Lino; Paganini, Claudio; Messner, Hubert; Radetti, G; Gentili, L; Paganini, C; Messner, H // European Journal of Pediatrics;2000, Vol. 159 Issue 7, p550 

    We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.

  • Outcome of Alagille Syndrome Patients Who Had Previously Received Kasai Operation during Infancy: A Single Center Study. Hwa Pyung Lee; Ben Kang; So Yoon Choi; Sanghoon Lee; Suk-Koo Lee; Yon Ho Choe // Pediatric Gastroenterology, Hepatology & Nutrition;Sep2015, Vol. 18 Issue 3, p175 

    Purpose: Infants with Alagille syndrome (AGS) are occasionally misdiagnosed as biliary atresia and subsequently undergo Kasai operation. The purpose of this study was to investigate the outcome of patients with AGS who had previously received Kasai operation during infancy. Methods: This...

  • Obstetric cholestasis. Milkiewicz, Piotr; Elias, Elwyn; Williamson, Catherine; Weaver, Judith // BMJ: British Medical Journal (International Edition);1/19/2002, Vol. 324 Issue 7330, p123 

    Editorial. Discusses the health consequences of obstetric cholestasis (OC), or intrahepatic cholestasis of pregnancy, for the mother and fetus. How it may lead to premature birth, fetal distress, and intrauterine death; Role of progesterone metabolites in its pathogenesis; Findings which have...

  • Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass... Mushtaq, Imran; Logan, Stuart // BMJ: British Medical Journal (International Edition);08/21/99, Vol. 319 Issue 7208, p471 

    Provides information on a study which assessed the feasibility of screening for cholestatic hepatobiliary disease and extra hepatic biliary atresia among newborn infants using tandem mass spectrometry. Diagnosis of the disease; Performance of the tandem mass spectrometry; Effect of storage on...

  • Management of neonatal cholestasis: Consensus statement of the pediatric gastroenterology chapter of Indian academy of pediatrics. Bhatia, Vidyut; Bavdekar, Ashish; Matthai, John; Waikar, Yogesh; Sibal, Anupam // Indian Pediatrics;Mar2014, Vol. 51 Issue 3, p203 

    Justification: Neonatal cholestasis is an important cause of chronic liver disease in young children. Late referral and lack of precise etiological diagnosis are reasons for poor outcome in substantial number of cases in India. There is a need to create better awareness among the pediatricians,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics